Chronic stress attenuates glucocorticoid negative feedback: Involvement of the prefrontal cortex and hippocampus

Neuroscience

Volumn 119, Issue 3, 2003, Pages 887-897

  Mizoguchi, K ^a   Ishige, A ^a   Aburada, M ^a   Tabira, T ^b  

^a TSUMURA AND CO   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Depression; Dexamethasone; Dexamethasone suppression test; Glucocorticoid receptor; Hypothalamus; Rat

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL LEVEL; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; HIPPOCAMPUS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; IMMOBILIZATION STRESS; IN SITU HYBRIDIZATION; MALE; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; WATER IMMERSION; WESTERN BLOTTING;

EID: 0038182090     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00105-2     Document Type: Article

References (60)

1. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry. 42:1985;1193-1204.
2. Beck C.A., Estes P.A., Bona B.J., Muro-Cacho C.A., Nordeen S.K., Edwards D.P. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology. 133:1993;728-740.
3. Belanoff J.K., Flores B.H., Kalezhan M., Sund B., Schatzberg A.F. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol. 21:2001;516-521.
4. Birmingham M.K., Sar M., Stumpf W.E. Dexamethasone target sites in the central nervous system and their potential relevance to mental illness. Cell Mol Neurobiol. 13:1993;373-386.
5. Calabrese J.R., Markovitz P.J. Treatment of depression new pharmacologic approaches . Prim Care. 18:1991;421-433.
6. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., James N.M., Kronfol Z., Lohr N., Steiner M., de Vigne J.P., Young E. A specific laboratory test for the diagnosis of melancholia standardization, validation and clinical utility . Arch Gen Psychiatry. 38:1981;15-22.
7. Cummings J.L. Depression and Parkinson's disease a review . Am J Psychiatry. 149:1992;443-454.
8. Dauvois S., White R., Parker M.G. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci. 106:1993;1377-1388.
9. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits implications for schizophrenia and Parkinson's disease . J Neural Transm. 91:1993;197-221.
10. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci. 13:1993;3839-3847.
11. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Frackowiak R.S. Neuropsychological dysfunction in depression the relationship to regional cerebral blood flow . Psychol Med. 24:1994;849-857.
12. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol. 27:2000;499-507.
13. Drevets W.C., Price J.L., Simpson J.R. Jr, Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
14. Feldman S., Conforti N. Modifications of adrenocortical responses following frontal cortex simulation in rats with hypothalamic deafferentations and medial forebrain bundle lesions. Neuroscience. 15:1985;1045-1047.
15. Feldman S., Weidenfeld J. Glucocorticoid receptor antagonists in the hippocampus modify the negative feedback following neural stimuli. Brain Res. 821:1999;33-37.
16. Fibiger H.C. Neurobiology of depression focus on dopamine . Adv Biochem Psychopharmacol. 49:1995;1-17.
17. Galigniana M.D., Housley P.R., DeFranco D.B., Pratt W.B. Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem. 274:1999;16222-16227.
18. Guiochon-Mantel A., Lescop P., Christin-Maitre S., Loosfelt H., Perrot-Applanat M., Malgrom E. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J. 10:1991;3851-3859.
19. Haynes R.C. Jr, Murad F. Adrenocorticotropic hormone adrenocortical steroids and their synthetic analogs: inhibitors of adrenocortical steroid biosynthesis . Gilman A.G., Goodman L.S., Rall T.W., Murad F. Goodman and Gilman's the pharmacological basis of therapeutics. 7th edition: 1985;1475 Macmillan Publishing Company, New York.
20. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology. 61:1995;180-190.
21. Herman J.P., Patel P.D., Akil H., Watson S.J. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol. 3:1989;1886-1894.
22. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test a refined laboratory test for psychiatric disorders . J Psychiatr Res. 28:1994;341-356.
23. Holsboer F. The dexamethasone suppression test in depressed patients clinical and biochemical aspects . J Steroid Biochem. 19:1983;251-257.
24. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structure role of corticosterone . Eur J Pharmacol. 165:1989;337-339.
25. Kalin N.H., Weiler S.J., Shelton S.E. Plasma ACTH and cortisol concentration before and after dexamethasone. Psychiatry Res. 7:1982;87-92.
26. Kellner M., Holsboer F., Heuser I. Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression. Psychiatry Res. 59:1995;157-160.
27. Kitraki E., Karandrea D., Kittas C. Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain. Neuroendocrinology. 69:1999;331-338.
28. Kov á cs K.J., Makara G.B. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 474:1988;205-210.
29. Lipsey J.R., Robinson R.G., Pearlson G.D., Rao K., Price T.R. The dexamethasone suppression test and mood following stroke. Am J Psychiatry. 142:1985;318-323.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Foline phenol reagent. J Biol Chem. 193:1951;265-275.
31. Lowy M.T. Corticosterone regulation of brain and lymphoid corticosteroid receptors. J Steroid Biochem Mol Biol. 39:1991;147-154.
32. Madan A.P., DeFranco D.B. Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA. 90:1993;3588-3592.
33. Magarinos A.M., Somoza G., De Nicola A.F. Glucocorticoid negative feedback and glucocorticoid receptors after hippocampectomy in rats. Horm Metab Res. 19:1987;105-109.
34. Mazure C.M. Does stress cause psychiatric illness? Spiegel D. Progress in psychiatry. 46:1995;270-298 American Psychiatric Press, Washington DC.
35. McEwen B.S. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog Brain Res. 93:1992;365-381.
36. Meijer O.C., de Lange E.C., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology. 139:1998;1789-1793.
37. Miller A.H., Spencer R.L., Pulera M., Kang S., McEwen B.S., Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone implications for the dexamethasone suppression test . Biol Psychiatry. 32:1992;850-869.
38. Mizoguchi K., Kunishita T., Chui D.H., Tabira T. Stress induces neuronal death in the hippocampus of castrated rats. Neurosci Lett. 138:1992;157-160.
39. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J Neurosci. 20:2000;1568-1574.
40. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology. 26:2001;443-459.
41. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T. Chronic stress impairs rotarod performance in rats implications for depressive state . Pharmacol Biochem Behav. 71:2002;79-84.
42. Mizoguchi K., Yuzurihara M., Nagata M., Ishige A., Sasaki H., Tabira T. Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment. Pharmacol Biochem Behav. 72:2002;723-728.
43. O'Donnell D., Francis D., Weaver S., Meaney M.J. Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue a comparison between Western blotting and receptor binding assays . Brain Res. 687:1995;133-142.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, New York.
45. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain microdistribution and differential occupation . Endocrinology. 117:1985;2505-2511.
46. Robinson R.G., Kubos K.L., Starr L.B., Rao K., Price T.R. Mood disorders in stroke patients importance of location of lesion . Brain. 107:(pt 1):1984;81-93.
47. Robinson R.G., Lipsey J.R., Bolla-Wilson K., Bolduc P.L., Pearlson G.D., Rao K., Price T.R. Mood disorders in left-handed stroke patients. Am J Psychiatry. 142:1985;1424-1429.
48. Rosewicz S., McDonald A.R., Maddux B.A., Goldfine I.D., Miesfeld R.L., Logsdon C.D. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem. 263:1988;2581-2584.
49. Rothschild A.J., Langlais P.J., Schatzberg A.F., Miller M.M., Saloman M.S., Lerbinger J.E., Cole J.O., Bird E.D. The effect of a single acute dose of dexamethasone on monoamine and metabolite levels in the rat brain. Life Sci. 36:1985;2491-2505.
50. Rybakowski J.K., Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res. 33:1999;363-370.
51. Sapolsky R.M., Krey L.C., McEwen B.S. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology. 114:1984;287-292.
52. Scherrer L.C., Dalman F.C., Massa E., Meshinchi S., Pratt W.B. Structural and functional reconstitution of the glucocorticoid receptor-hsp90 complex. J Biol Chem. 265:1990;21397-21400.
53. Schmider J., Lammers C.H., Gotthardt U., Dettling M., Holsboer F., Heuser I.J. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls I . Biol Psychiatry. 38:1995;797-802.
54. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:1996;3908-3913.
55. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 32:1992;756-765.
56. Steckler T., Holsboer F., Reul J.M. Glucocorticoids and depression. Bailli è res Best Pract Res Clin Endocrinol Metab. 13:1999;597-614.
57. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex a trait of drugs with antidepressant potential? Psychopharmacology (Berl). 115:1994;285-288.
58. Versteeg D.H.G., van Zoest I., de Kloet E.R. Acute changes in dopamine metabolism in the medial basal hypothalamus following adrenalectomy. Experientia. 40:1983;112-114.
59. Watanabe Y., Gould E., McEwen B.S. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 588:1992;341-345.
60. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression a prospective study . J Psychiatr Res. 35:2001;83-94.